Please login to the form below

Not currently logged in
Email:
Password:

Amgen appoints Wanda Austin to its Board

She will also serve as a member of the firm's audit committee

Amgen has appointed Wanda Austin to its board of directors and as a member of its audit committee and corporate responsibility and compliance committee.

Austin most recently retired from her role as president and chief executive officer of space programme The Aerospace Corporation, where she has served from 2008 to 2016.

Robert Bradway, chairman and chief executive officer, Amgen, said: “We are pleased to welcome Dr Wanda Austin to Amgen’s board.

“Wanda’s deep experience in long-cycle technology and engineering settings and her senior leadership experience will be invaluable to Amgen.”

The addition of Austin will see Amgen’s board comprise of 14 directors, 13 of whom are independent of the company.

2nd November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...

Infographics